Cationic antimicrobial peptides and their multifunctional role in the immune system

Critical Reviews in Immunology

Volumn 20, Issue 5, 2000, Pages 407-431

  Scott, M G ^a   Hancock, R E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Antimicrobial; Cationic peptides; Inflammation; Innate immunity; Lipopolysaccharide

Indexed keywords

ANTIINFECTIVE AGENT; BACTENECIN; CATION; CECROPIN; DEFENSIN; HISTATIN; INDOLICIDIN; PEPTIDE; POLYMYXIN B; PROTEGRIN; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BINDING AFFINITY; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SEPSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; ANTIVIRAL AGENTS; DRUG SYNERGISM; HUMANS; MOLECULAR SEQUENCE DATA; SEPSIS;

EID: 0034488452     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (185)

1. Antimicrobial peptides from insects
2. Animal antimicrobial peptides: An overview
3. Cationic peptides: A new source of antibiotics
4. Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system
5. Purification and characterization of defensins from cystic fibrosis sputum
6. Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis
7. Establishment of radioimmunoassay for human neutrophil peptides and their increases in plasma and neutrophil in infection
8. Elevated pleural fluid levels of defensins in patients with empyema
9. Defensin-1, an antimicrobial peptide present in the saliva of patients with oral diseases
10. Levels of human defensin-1, an antimicrobial peptide, in saliva of patients with oral inflammation
11. Neutrophil defensins induce histamine secretion from mast cells: Mechanisms of action
12. Magainin-2 releases histamine from rat mast cells
13. Chemoattractant properties of PR-39, a neutrophil antibacterial peptide
14. Monocyte-chemotactic activity of defensins from human neutrophils
15. Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils
16. Beta-defensins: Linking innate and adaptive immunity through dendritic and T cell CCR6
17. Interaction of macrophage cationic proteins with the outer membrane of Pseudomonas aeruginosa
18. Defensins are mitogenic for epithelial cells and fibroblasts
19. Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds
20. Human neutrophil defensin and serpins form complexes and inactivate each other
21. Chemotactic and protease-inhibiting activities of antibiotic peptide precursors
22. Defensins and innate host defence of the gastrointestinal tract
23. Gene-encoded peptide antibiotics and the concept of innate immunity: An update review
24. Diversity of antimicrobial peptides and their mechanisms of action
25. Antimicrobial peptides of vertebrates
26. Peptide antibiotics
27. The role of antimicrobial peptides in animal defenses
28. Beta-defensins: Endogenous antibiotics of the innate host defense response
29. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes
30. Antimicrobial peptides as potential new antifungals
31. IV. Paneth cell antimicrobial peptides and the biology of the mucosal barrier
32. Human beta-defensin-2
33. Defensins: Key players or bystanders in infection, injury, and repair in the lung?
34. Epithelial antimicrobial peptides: Review and significance for oral applications
35. Human enteric defensin genes: Chromosomal map position and a model for possible evolutionary relationships
36. The human beta-defensin-1 and alpha-defensins are encoded by adjacent genes: Two peptide families with differing disulfide topology share a common ancestry
37. Cathelicidins: A novel protein family with a common proregion and a variable C-terminal antimicrobial domain
38. The structure of porcine protegrin genes
39. Structures of genes for two cathelin-associated antimicrobial peptides: Prophenin-2 and PR-39
40. Porcine polymorphonuclear leukocytes generate extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins
41. Role of CCAAT/enhancer-binding protein site in transcription of human neutrophil peptide-1 and -3 defensin genes
42. Induction of a rat enteric defensin gene by hemorrhagic shock
43. Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract
44. Cloning and expression of bovine neutrophil beta-defensins. Biosynthetic profile during neutrophilic maturation and localization of mature peptide to novel cytoplasmic dense granules
45. Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelial cells
46. Coordinate induction of two antibiotic genes in tracheal epithelial cells exposed to the inflammatory mediators lipopolysaccharide and tumor necrosis factor alpha
47. Transcriptional regulation of beta-defensin gene expression in tracheal epithelial cells
48. Synergistic actions of antibacterial neutrophil defensins and cathelicidins
49. Production of beta-defensins by human airway epithelia
50. CD14-dependent LPS-induced {beta}-defensin-2 expression in human tracheobronchial epithelium
51. Cathelicidin gene expression in porcine tissues: Roles in ontogeny and tissue specificity
52. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils
53. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis
54. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders
55. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface
56. Direct inactivation of viruses by human granulocyte defensins
57. Defensins
58. Host defense mechanism in Aspergillus fumigatus infections
59. Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activity
60. Improvement in survival with peptidyl membrane interactive molecule D4B treatment after burn wound infection
61. Antiendotoxin activity of cationic peptide antimicrobial agents
62. Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia
63. Effect of local application of the antimicrobial peptide IB-367 on the incidence and severity of oral mucositis in hamsters
64. Evaluation of the use of xanthan as vehicle for cationic antifungal peptides
65. Protegrin-1: A broad-spectrum, rapidly microbicidal peptide with in vivo activity
66. Antimicro-bial peptides protect coho salmon from Vibrio anguillarum infections
67. Plant defense peptides
68. Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide
69. Interleukin 2 promoter/enhancer controlled expression of a synthetic cecropin-class lytic peptide in transgenic mice and subsequent resistance to Brucella abortus
70. Epithelial defensins impair adenoviral infection: Implication for adenovirus-mediated gene therapy
71. Plant defensins: Novel antimicrobial peptides as components of the host defense system
72. Activity of abundant antimicrobials of the human airway
73. Salmonella infection increases porcine antibacterial peptide concentrations in serum
74. Identification of human beta-defensin-2 in respiratory tract and plasma and its increase in bacterial pneumonia
75. Enteric beta-defensin: Molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection
76. Epithelial antibiotic induced in states of disease
77. Mouse beta-defensin 3 is an inducible antimicrobial peptide expressed in the epithelia of multiple organs
78. Expression and regulation of the human beta-defensins hBD- 1 and hBD-2 in intestinal epithelium
79. Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands
80. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense
81. Mechanism of synergism between antimicrobial peptides magainin 2 and PGLa
82. The interaction of a recombinant cecropin/melittin hybrid peptide with the outer membrane of Pseudomonas aeruginosa
83. Biological properties of structurally related alpha-helical cationic antimicrobial peptides
84. In vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action
85. Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane
86. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein
87. CD14 and innate recognition of bacteria
88. Interactions of lipopolysaccharide with neutrophils in blood via CD14
89. LPS binding protein and CD14 in the LPS dependent activation of cells
90. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction
91. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the LPS gene product
92. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
93. Genetic and physical mapping of the LPS locus: Identification of the Toll-4 receptor as a candidate gene in the critical region
94. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4)
95. Endotoxin opens the Tollgates to innate immunity
96. The role of tyrosine kinases and map kinases in LPS-induced signaling
97. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
98. Recognition of endotoxin by cells leading to transmembrane signaling
99. Recognition of gram-negative bacteria and endotoxin by the innate immune system
100. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro
101. Lipopolysaccharide (LPS)-binding synthetic peptides derived from serum amyloid P component neutralize LPS
102. Synthetic endotoxin-binding peptides block endotoxin-triggered TNF-alpha production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock
103. Endotoxin-binding synthetic peptides with endotoxin-neutralizing, antibacterial and anticoagulant activities
104. Structure and functions of endotoxin-binding peptides derived from CAP18
105. Influence of synthetic antiendotoxin peptides on lipopolysaccharide (LPS) recognition and LPS-induced proinflammatory cytokine responses by cells expressing membrane-bound CD14
106. Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins
107. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/ permeability-increasing protein of human neutrophils
108. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils
109. Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide
110. Recombinant human bactericidal/permeability-increasing protein (rBPI23) is a universal lipopolysaccharide-binding ligand
111. A synthetic lipopolysaccharide-binding peptide based on the neutrophil-derived protein CAP37 prevents endotoxin-induced responses in conscious rats
112. Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein
113. Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity
114. Human CAP18: A novel antimicrobial lipopolysaccharide-binding protein
115. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity
116. Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide
117. Bactericidal permeability-increasing protein in host defence against gram-negative bacteria and endotoxin
118. Cutting edge: Cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein
119. A synthetic α-helical cationic antimicrobial peptide selectively modulates macrophage response to LPS and directly alters macrophage gene expression
120. PR-39, a syndecan-inducing antimicrobial peptide, binds and affects p130(Cas)
121. Cytotoxicity and apoptosis mediated by two peptides of innate immunity
122. Inhibition of protein kinase C by defensins, antibiotic peptides from human neutrophils
123. Anticancer efficacy of Magainin2 and analogue peptides
124. Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation
125. Synergistic cytolysis mediated by hydrogen peroxide combined with peptide defensins
126. Mechanism of target cytolysis by peptide defensins. Target cell metabolic activities, possibly involving endocytosis, are crucial for expression of cytotoxicity
127. Antitumor activity of magainin analogues against human lung cancer cell lines
128. NK-lysin, a novel effector peptide of cytotoxic T and NK cells. Structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumour activity
129. Molecular basis of host-pathogen interaction in septic shock
130. Serum-induced potentiation of tumor necrosis factor alpha production by human monocytes in response to staphylococcal peptidoglycan: Involvement of different serum factors
131. Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD14 antigen, and mannan binding protein inhibits TNF-alpha release
132. Capsular polysaccharide types 5 and 8 of Staphylococcus aureus bind specifically to human epithelial (KB) cells, endothelial cells and monocytes and induce release of cytokines
133. Structural characteristics of peptidoglycan fragments required to prime mice for induction of anaphylactoid reactions by lipopolysaccharides
134. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure
135. Mechanism of gram-positive shock: Identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure
136. Streptococcus mitis cell walls and lipopolysaccharide induce lethality in D-galactosamine-sensitized mice by a tumor necrosis factor-dependent pathway
137. Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock
138. Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli
139. Gram-positive organisms and sepsis
140. Interaction of cationic peptides with lipoteichoic acid and gram-positive bacteria
141. Lymphocyte trafficking and regional immunity
142. Chemotaxis of mononuclear cells
143. CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity
144. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils
145. Neutrophil-derived heparin-binding protein: A monocyte-specific chemoattractant that induces monocyte migration into rabbit lungs in vivo
146. Covalent structure of two novel neutrophil leucocyte-derived proteins of porcine and human origin. Neutrophil elastase homologues with strong monocyte and fibroblast chemotactic activities
147. Effect of defensins on interleukin-8 synthesis in airway epithelial cells
148. Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation
149. Comparative studies on the extracellular release and biological activity of guinea pig neutrophil cationic antibacterial polypeptide of 11 kDa (CAP11) and defensins
150. New concepts about the mast cell
151. Activation of rat peritoneal mast cells by substance P and mastoparan
152. G protein activation: A receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides
153. Mast cell heterogeneity: Effects of neuroenteric peptides on histamine release
154. Evaluation of the effects of defensins on neutrophil functions
155. Signal transduction by cell adhesion receptors in leukocytes
156. Leukocyte-endothelial adhesion molecules
157. The in vitro effect of human polymorphonuclear leukocyte azurophil granule components on natural killer cell cytotoxicity
158. Defensins impair phagocytic killing by neutrophils in biomaterial-related infection
159. Apoptosis in human leukemic cells induced by lacto-ferricin, a bovine milk protein-derived peptide: Involvement of reactive oxygen species
160. Defensin interferes with the activation of neutrophil NADPH oxidase in a cell-free system
161. Cationic proteins of neutrophil azurophilic granules: Protein-protein interaction and blockade of NADPH oxidase activation
162. Biomaterial-induced alterations of neutrophil superoxide production
163. PR-39, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47 phox
164. Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+
165. PR-39, a proline/arginine-rich antimicrobial peptide, prevents postischemic microvascular dysfunction
166. Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium
167. Activated human peripheral blood neutrophils produce epithelial injury and fibronectin breakdown in vitro
168. Degradation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonuclear leukocyte granules
169. Specific cleavage of human type III collagen by human polymorphonuclear leukocyte elastase
170. Study of human epithelial cell detachment and damage: Effects of proteases and oxidants
171. Direct cytotoxicity of polymorphonuclear leukocyte granule proteins to human lung-derived cells and endothelial cells
172. Histidine-rich human salivary peptides are inhibitors of proprotein convertases furin and PC7 but act as substrates for PC1
173. Leukocytic antimicrobial peptides kill auto-immune T cells
174. Effect of neutrophil serine proteinases and defensins on lung epithelial cells: Modulation of cytotoxicity and IL-8 production
175. Cellular detachment and deformation induce IL-8 gene expression in human bronchial epithelial cells
176. The effect of HP-1 and related neutrophil granule peptides on DNA synthesis in HL60 cells
177. Enhanced in vitro growth of murine fibroblast cells and preimplantation embryos cultured in medium supplemented with an amphipathic peptide
178. Proline-rich antimicrobial peptide, PR-39 gene transduction altered invasive activity and actin structure in human hepatocellular carcinoma cells
179. Identification of defensin binding to C1 complement
180. Defensins purified from human granulocytes bind C1q and activate the classical complement pathway like the transmembrane glycoprotein gp41 of HIV-1
181. Inhibition of activation of the classical pathway of complement by human neutrophil defensins
182. Host defence (cationic) peptides: What is their future clinical potential?